2017
DOI: 10.3389/fneur.2017.00229
|View full text |Cite
|
Sign up to set email alerts
|

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Abstract: Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous studies have shown differences in MS health outcomes between countries. This study aimed to examine the associations between international regions and health outcomes in people with MS. Self-reported data were taken from the Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis online survey collected in 2012. The 2,401 participants from 37 countries were categorized into three regions: Austral… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…Physicians and/or researchers administered the assessment in four studies [ 17 , 19 , 43 , 44 ] and seven studies did not specify an administration method [ 45 – 51 ]. Most studies ( n = 25 studies) were conducted in Europe, North America, and Australasia [ 18 , 21 24 , 26 33 , 36 39 , 42 , 43 , 45 , 48 – 52 ] and an additional five records were linked to the same international study in which most of the participants reported living in North America, Australasia, and Europe [ 11 , 25 , 34 , 35 , 40 ]. The remaining five datasets were from South America, the Middle East, or the region was not reported [ 17 , 19 , 20 , 46 , 47 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Physicians and/or researchers administered the assessment in four studies [ 17 , 19 , 43 , 44 ] and seven studies did not specify an administration method [ 45 – 51 ]. Most studies ( n = 25 studies) were conducted in Europe, North America, and Australasia [ 18 , 21 24 , 26 33 , 36 39 , 42 , 43 , 45 , 48 – 52 ] and an additional five records were linked to the same international study in which most of the participants reported living in North America, Australasia, and Europe [ 11 , 25 , 34 , 35 , 40 ]. The remaining five datasets were from South America, the Middle East, or the region was not reported [ 17 , 19 , 20 , 46 , 47 ].…”
Section: Resultsmentioning
confidence: 99%
“…The 12 studies that measured fatigue using a validated scale, did not restrict enrolment to CIS only, and did not restrict by level of disability may provide the most reliable and generalizable estimates of fatigue prevalence in the overall MS population. The prevalence of fatigue in these studies ranged from 36.5 to 78.0% [ 11 , 18 , 21 , 25 , 28 , 34 , 35 , 40 , 42 , 47 , 50 , 51 ]. Eight of these studies (describing nine datasets) recruited 300 or more participants, the number required to estimate fatigue prevalence in pwMS with a standard error of ≤5%, assuming that fatigue prevalence was 60%; these studies reported prevalence estimates ranging from 36.5 to 78.0% [ 11 , 25 , 34 , 35 , 40 , 42 , 48 , 50 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…They also observed that the distribution of physical activity levels varied between regions. Whereas, 29.9% of PwMS were classi ed at a high physical activity level in North America, only 22.2% were classi ed at that level in Europe [11].…”
Section: Introductionmentioning
confidence: 90%
“…Only sparse data exist relating to the physical activity participation of PwMS from different environmental backgrounds. Reily et al [11] examined the prevalence of various comorbidities and modi able lifestyle factors in PwMS, including the level of physical activity performed in different global regions (Australia, Europe, and North America). The authors found a strong inverse relationship between the level of physical inactivity and the physical aspects of quality of life in the total cohort.…”
Section: Introductionmentioning
confidence: 99%